Progressive Sopranuclear Palsy


The Progressive Sopranucelar Palsy (PSP) is a neurodegenerative disease that affects brain cells involved in balance control, walking, coordination, eye movement, language, swallowing and cognitive functions. Five to six people out of 100,000 have PSP. On average, symptoms begin around the age of 60 y-o, but can start earlier. It is slightly more common in men, but has no known geographical, professional or racial preferences.

Our center, in addition to traditional therapeutic approaches, is one of the first in the world to experiment infusion therapies with monoclonal antibodies and other innovative treatments.

For info e-mail